CRISPR Therapeutics AG
CRSP
Market Cap$3.13B
Close$
$-3.57
109.4% downside
Current Fair Value
109.4% downsideOvervalued by 109.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.13 Billion |
|---|---|
| Enterprise Value | $3.12 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.34 |
| Beta | 1.87 |
| Outstanding Shares | 85,938,720 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.09 |
|---|---|
| PEG | -48.59 |
| Price to Sales | - |
| Price to Book Ratio | 1.81 |
| Enterprise Value to Revenue | 86.45 |
| Enterprise Value to EBIT | -6.52 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About CRISPR Therapeutics AG
CEO: Samarth Kulkarni